Glenmark Life Sciences Share Price

NSE
GLS •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Glenmark Life Sciences Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
25.56% Fall from 52W High
-13.7
TTM PE Ratio
Below industry Median
28.8
Price to Book Ratio
Below industry Median
5.2
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-1.8

Glenmark Life Sciences Ltd shareholding Pattern

Promoter
75%
Foreign Institutions
7.8%
Mutual Funds
2.8%
Domestic Institutions
4.2%
Public
13%
Promoter
82.8%
Foreign Institutions
4.8%
Mutual Funds
1%
Domestic Institutions
1.6%
Public
10.8%
Promoter
82.8%
Foreign Institutions
5%
Mutual Funds
0.9%
Domestic Institutions
1.4%
Public
10.7%
Promoter
82.8%
Foreign Institutions
4.6%
Mutual Funds
0.6%
Domestic Institutions
0.7%
Public
11.8%
Promoter
82.8%
Foreign Institutions
4.4%
Mutual Funds
0.4%
Domestic Institutions
0.6%
Public
12.1%
Promoter
82.8%
Foreign Institutions
3.3%
Mutual Funds
0.5%
Domestic Institutions
0.5%
Public
13.3%

Glenmark Life Sciences Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
14
5Day EMA
1,011.80
10Day EMA
1,023.70
12Day EMA
1,027.60
20Day EMA
1,039.90
26Day EMA
1,046.60
50Day EMA
1,059.40
100Day EMA
1,040.20
200Day EMA
964.80
5Day SMA
1,013.50
10Day SMA
1,024.00
20Day SMA
1,048.50
30Day SMA
1,059.40
50Day SMA
1,069.20
100Day SMA
1,075.00
150Day SMA
1,001.40
200Day SMA
949.40
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
57703 Rs
111101 Rs
Week Rs
43303 Rs
87346 Rs
Month Rs
80669 Rs
127641 Rs
Resistance & Support
999.48
Pivot
Resistance
First Resistance
1,013.22
Second Resistance
1,032.53
Third Resistance
1,046.27
Support
First Support
980.17
Second support
966.43
Third Support
947.12
Relative Strength Index
37.43
Money Flow Index
51.42
MACD
-18.99
MACD Signal
-14.51
Average True Range
39.18
Average Directional Index
18.20
Rate of Change (21)
-4.95
Rate of Change (125)
19.24

Glenmark Life Sciences Ltd Company background

Founded in: 2011
Managing director: Yasir Yusufali Rawjee
Glenmark Life Sciences Limited was incorporated as Zorg Laboratories Private Limited, on June 23, 2011 at Pune and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra at Pune. Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited dated 10 August 2018. A shareholders resolution was passed on 13 August 2018 to convert the Company from a Private Limited Company to a Public Limited Company and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The Company is a wholly owned Subsidiary of Glenmark Pharmaceuticals Limited. The Company acquired API Division of Glenmark Pharmaceuticals Limited (the parent company) on 01 January, 2019.The Company is engaged in the business of development, manufacture and marketing of Active Pharmaceutical Ingredients(APIs). In 2001, Glenmark Pharmaceuticals established its API business. The first product registered with USFDA in 2003. The Company acquired Glaxo SmithKlines (GSK) API manufacturing plant in Ankleshwar, Gujarat in 2003. It established manufacturing plant at Kurkumbh, Maharashtra in 2002. In 2004, it commenced manufacturing at Mohol, Maharashtra. In 2013, the Company commenced manufacturing at Dahej, Gujarat. The Company increased its API manufacturing capabilities by enhancing the existing production capacities at Ankleshwar Dahej facilities in FY 2023, by an aggregate annual total installed capacity of 640 KL.The Company expanded projects with additional 240 KL at Dahej in 2023. The brownfield expansion at Dahej for Oncology Plant was completed. Out of the 2 independent modules, one module commissioned 100%. 192 KL out of the 400 KL intermediate manufacturing block at Ankleshwar commissioned in 2023. The Company came up with an IPO of 21,022,222 Equity Shares comprising a Fresh Issue of 14,722,222 Equity Shares and Offer for Sale of 6,300,000 Equity Shares aggregating to Rs 1513.6 Crores in August, 2021.
Read More

Glenmark Life Sciences Ltd FAQs

Glenmark Life Sciences Ltd shares are currently priced at 993.9 on NSE and 993.55 on BSE as of 12/20/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Glenmark Life Sciences Ltd [GLS] share was 54. The Glenmark Life Sciences Ltd [GLS] share hit a 1-year low of Rs. 627.15 and a 1-year high of Rs. 1335.1.

The market cap of Glenmark Life Sciences Ltd is Rs. 12178.54 Cr. as of 12/20/2024 12:00:00 AM.

The PE ratios of Glenmark Life Sciences Ltd is 28.75 as of 12/20/2024 12:00:00 AM.

The PB ratios of Glenmark Life Sciences Ltd is 4.79 as of 12/20/2024 12:00:00 AM

The Mutual Fund Shareholding was 2.82% at the end of 12/20/2024 12:00:00 AM.

You can easily buy Glenmark Life Sciences Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -